ArticleCell reports. Medicine2024

A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers.

Mohammed M Alruwaili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.